Literature DB >> 15867021

Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Jeffrey B Schwimmer1, Nancy McGreal, Reena Deutsch, Milton J Finegold, Joel E Lavine.   

Abstract

OBJECTIVES: Fatty liver is a common cause of liver disease in children. However, the epidemiology of pediatric fatty liver is limited to single-center case series of nonalcoholic fatty liver disease (NAFLD). Obesity and insulin resistance are major established risk factors for NAFLD. The role of gender, race, and ethnicity on the prevalence of fatty liver in obese children is unknown.
METHODS: We recruited obese 12th-grade participants from the Child and Adolescent Trial for Cardiovascular Health in California, Louisiana, Minnesota, and Texas. Serum samples were collected at school when the participants were well. Alanine aminotransferase (ALT) was measured by kinetic enzymatic assay, and ALT >40 U/L was defined as abnormal. Causes of abnormal ALT other than NAFLD were excluded by serum testing.
RESULTS: A total of 127 obese students (73 female, 54 male) had a mean BMI of 35.2 kg/m2. Unexplained ALT elevation was present in 23% of participants overall. The mean ALT for participants with normal values was 28 U/L and for participants with an abnormal ALT was 56 U/L. Abnormal ALT was significantly more prevalent in boys (44%) than in girls (7%). The prevalence of abnormal ALT differed significantly by race and ethnicity (Hispanic: 36%; white: 22%; black: 14%). Serum ALT value was significantly predicted by the combination of gender, race/ethnicity, and BMI. After controlling for gender and BMI, Hispanic ethnicity significantly predicted greater ALT than black race.
CONCLUSIONS: In a national, school-based sample of obese adolescents, boys were 6 times more likely than girls to have an unexplained elevated ALT. Given that participants were well and causes of chronic liver disease were excluded, we speculate that obese adolescent boys have an increased prevalence of fatty liver compared with obese adolescent girls. This population-based study also supports the hypothesis that NAFLD is more common in Hispanic adolescents. These findings have implications for both disease screening and studies of fatty liver pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867021     DOI: 10.1542/peds.2004-1832

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  121 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Fatty liver disease in children: eat now pay later.

Authors:  Ruth M L De Bruyne; Emer Fitzpatrick; Anil Dhawan
Journal:  Hepatol Int       Date:  2010-01-29       Impact factor: 6.047

3.  Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

4.  Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.

Authors:  Eric R Kallwitz; Mrudula Kumar; Radhika Aggarwal; Reed Berger; Jennifer Layden-Almer; Neil Gupta; Scott J Cotler
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

5.  Ethnic differences in the link between insulin resistance and elevated ALT.

Authors:  Mark D Deboer; R Constance Wiener; Barrett H Barnes; Matthew J Gurka
Journal:  Pediatrics       Date:  2013-08-12       Impact factor: 7.124

6.  The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children.

Authors:  Selim Gökçe; Zehra Atbinici; Zehra Aycan; Hasibe Gökçe Cınar; Pelin Zorlu
Journal:  Pediatr Cardiol       Date:  2012-08-09       Impact factor: 1.655

7.  Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.

Authors:  Charlene A Wong; Maria Rosario G Araneta; Elizabeth Barrett-Connor; John Alcaraz; Donna Castañeda; Carol Macera
Journal:  Diabetes Res Clin Pract       Date:  2007-08-30       Impact factor: 5.602

Review 8.  Managing nonalcoholic fatty liver disease: recommendations for family physicians.

Authors:  Ignazio Grattagliano; Piero Portincasa; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

9.  Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.

Authors:  Miriam B Vos; Shirish Barve; Swati Joshi-Barve; John D Carew; Peter F Whitington; Craig J McClain
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-10       Impact factor: 2.839

10.  Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.

Authors:  Diana R Mager; Simon Ling; Eve A Roberts
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.